clinical practice guidelines
Squamous cell carcinoma of the head and neck: EHNS–ESMO–ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up

https://doi.org/10.1093/annonc/mdq185Get rights and content
Under an Elsevier user license
open archive

Cited by (0)

Approved by the ESMO Guidelines Working Group: June 2002, last update February 2010. This publication supercedes the previously published version-Ann Oncol 2009; 20 (Suppl 4): iv121-iv122

Conflict of interest: Prof. Gregoire has reported no conflicts of interest, Prof. Lefebvre has reported that he is a lecturer and a member of the advisory boards of MerckSerono and Sanofi-Aventis; Dr Licitra has reported that she is on the Advisory Board of BMS, Glaxo, Lilly, Merk-Serono and Amgen; her institution has received funds for clinical studies and research activities in which she is involved from EISAI, Exelixis, Lilly, Merk-Serono, Amgen; she has received travel coverages to attend medical meetings from Merk-Serono; Dr Felip has reported no conflicts of interest.